Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-26

FDA Approved: MYCAPSSA — Original Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved MYCAPSSA, an oral formulation of octreotide from Chiesi USA, representing the original approval of an oral octreotide product for adults with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYCAPSSA (OCTREOTIDE)

Snippet

ORIG AP for MYCAPSSA (OCTREOTIDE)